Skip to main content

DIADEMA PARTNERS LP

Position in VKTX — Viking Therapeutics, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,234,930
+$145,541 QoQ
Shares Held
441,808
-15.9% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
6.51%
of 13F equity value
Holder Rank
#36
of 432 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Jun 30, 2026
CallValue
$47,623,408
CallShares
1,220,800
PutValue
$13,673,005
PutShares
350,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names. VKTX ranks #5 (7.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 VKTX
Viking Therapeutics, Inc.
This page
441,808 $17,234,930

All Filings in VKTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,623,408 1,220,800
2026-06-30 $13,673,005 350,500
2026-06-30 $17,234,930 441,808
2026-03-31 $21,450,368 659,200
2026-03-31 $17,089,389 525,181
2025-12-31 $24,235,502 688,900
2025-12-31 $11,850,347 336,849
2025-12-31 $11,141,506 316,700
2025-09-30 $10,646,028 405,100
2025-09-30 $5,090,146 193,689
2025-06-30 $5,232,902 197,468
2025-03-31 $2,514,522 104,121
2025-03-31 $1,207,500 50,000